A state-of-the-art facility working to develop mouse models for Mito CMTs, including the MTRFR/C12orf65 gene to test repurposed drugs and gene therapies targeting the optic nerve and other phenotypes of disease.
Changes how this site looks for you, and are saved on this device.
We use cookies to see how the site is used (analytics) and to power embedded videos and podcasts. Analytics stay off until you say yes. See our privacy policy.
Be the first to know
Research moves fast. Add your number and we will text you the things that matter most: new treatment news, trial openings, and ways to take part before they fill up.